Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Revenue $ 7,510 $ 7,356 $ 21,529 $ 18,788
Cost of revenue 7,161 8,472 21,583 20,200
Gross profit (loss) 349 (1,116) (54) (1,412)
Operating expenses        
Research and development 5,971 7,349 22,729 25,079
General and administrative expenses 8,935 8,817 28,453 21,650
Other operating expenses 8,051 8,051
Total operating expenses 22,957 16,166 59,233 46,729
Loss from operations (22,608) (17,282) (59,287) (48,141)
Other (expense) income        
Interest (expense) income (745) (510) (1,909) (1,955)
Other (expense) income (5) (2) (4) (10)
Change in fair value of contingent consideration 268 1,438
Change in fair value of derivative liabilities 52 (383) 2,058 456
Total other (expense) income (698) (627) 145 (71)
Net loss before income taxes (23,306) (17,909) (59,142) (48,212)
Income Taxes (2) 2,364 (5) 2,420
Net Loss $ (23,308) $ (15,545) $ (59,147) $ (45,792)
Net loss per common share - basic (in Dollars per share) $ (0.26) $ (0.23) $ (0.75) $ (0.75)
Weighted average common shares outstanding - basic (in Shares) 91,281,779 68,195,181 78,845,986 60,925,124